Dongguan, China
Taixin Hospital, No.2 Taixin Road, Lixin Management District, Dongcheng District, Dongguan City, Guangdong, China
Distance from Airport : 59 Km
Distance from Railway Station : 24km way from Dongguan Railway station
Get priority response from GoBroad Healthcare (Hematology) Guangdong Research Center Center

GoBroad Healthcare (Hematology) Guangdong Research Center employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2018, the accredited hospital is located in Dongguan, China and has 200 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Expected Price: USD120000GoBroad Healthcare (Hematology) Guangdong Research Center offers advanced Chemotherapy using modern oncology protocols and individualized treatment plans. Established in 2018, the accredited hospital is located in Dongguan, China and has 200 beds, providing comprehensive cancer care for local and international patients.
Chemotherapy uses medicines that destroy cancer cells or slow their growth. It may be used to treat many types of cancer and can be given before surgery or radiation to shrink a tumor, after surgery to reduce the risk of recurrence, or as the main treatment when surgery is not appropriate. Depending on the cancer, chemotherapy may be administered intravenously, orally, or through other routes. The drugs and treatment schedule are selected according to the cancer type, stage, and patient's overall health.
Expected Price: USD1000Choosing GoBroad Healthcare (Hematology) Guangdong Research Center for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2018, the accredited hospital is located in Dongguan, China and operates 200 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
Expected Price: USD2500At GoBroad Healthcare (Hematology) Guangdong Research Center, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2018, the accredited hospital is located in Dongguan, China, and has 200 beds.
Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.
Choosing GoBroad Healthcare (Hematology) Guangdong Research Center for Bone Marrow Transplant gives patients access to experienced transplant specialists, advanced technology, and comprehensive medical care. Established in 2018, the accredited hospital in Dongguan, China has 200 beds and provides specialized transplant services.
Bone Marrow Transplant may be considered for patients with conditions such as leukemia, lymphoma, multiple myeloma, aplastic anemia, and selected inherited blood disorders. The transplant process generally includes disease assessment, stem cell collection, conditioning therapy, stem cell infusion, and close follow-up. Depending on the clinical situation, patients may receive their own stem cells or cells obtained from a suitable donor. The transplant team monitors blood counts, infections, organ function, and other factors throughout recovery.
Expected Price: USD55000
